Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

0.64
Delayed Data
As of Apr 29
 0.00 / 0.00%
Today’s Change
0.22
Today|||52-Week Range
2.00
-8.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$13.9M

Company Description

Alexza Pharmaceuticals, Inc. is a pharmaceutical company, which is focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni on December 19, 2000 and is headquartered in Mountain View, CA.

Contact Information

Alexza Pharmaceuticals, Inc.
2091 Stierlin Court
Mountain View California 94303
P:(650) 944-7000
Investor Relations:
(650) 944-7900

Employees

Shareholders

Mutual fund holders7.76%
Individual stakeholders18.33%
Other institutional15.53%

Top Executives

Thomas Braxton KingPresident, CEO, CFO, Director & CAO
Catherine McAuliffeVice President-Operations
Edwin S. KamemotoExecutive VP-Quality, Research & Development
Lori H. TakahashiVice President-Pharmaceutical R&D
Tatjana NarandaVP-Business Development & Alliance Management